484 related articles for article (PubMed ID: 29165358)
21. Metastatic Basal Cell Carcinoma of the Skin: A Comprehensive Literature Review, Including Advances in Molecular Therapeutics.
Bisceglia M; Panniello G; Galliani CA; Centola M; D'Errico MM; Minenna E; Tucci FA; Ben-Dor DJ
Adv Anat Pathol; 2020 Sep; 27(5):331-353. PubMed ID: 32618586
[TBL] [Abstract][Full Text] [Related]
22. Heterozygous mutations in the tumor suppressor gene PATCHED provoke basal cell carcinoma-like features in human organotypic skin cultures.
Brellier F; Bergoglio V; Valin A; Barnay S; Chevallier-Lagente O; Vielh P; Spatz A; Gorry P; Avril MF; Magnaldo T
Oncogene; 2008 Nov; 27(51):6601-6. PubMed ID: 18679421
[TBL] [Abstract][Full Text] [Related]
23. Frequency and features of TP53 mutation in 30 Chinese patients with sporadic basal cell carcinoma.
Wang YM; Huang YS; Ma ZH; Bu DF; Wang Y; Tu P; Li H
Clin Exp Dermatol; 2014 Oct; 39(7):829-34. PubMed ID: 25196205
[TBL] [Abstract][Full Text] [Related]
24. Frequent DPH3 promoter mutations in skin cancers.
Denisova E; Heidenreich B; Nagore E; Rachakonda PS; Hosen I; Akrap I; Traves V; García-Casado Z; López-Guerrero JA; Requena C; Sanmartin O; Serra-Guillén C; Llombart B; Guillén C; Ferrando J; Gimeno E; Nordheim A; Hemminki K; Kumar R
Oncotarget; 2015 Nov; 6(34):35922-30. PubMed ID: 26416425
[TBL] [Abstract][Full Text] [Related]
25. SOX9 Transcriptionally Regulates mTOR-Induced Proliferation of Basal Cell Carcinomas.
Kim AL; Back JH; Chaudhary SC; Zhu Y; Athar M; Bickers DR
J Invest Dermatol; 2018 Aug; 138(8):1716-1725. PubMed ID: 29550418
[TBL] [Abstract][Full Text] [Related]
26. The molecular genetics underlying basal cell carcinoma pathogenesis and links to targeted therapeutics.
Iwasaki JK; Srivastava D; Moy RL; Lin HJ; Kouba DJ
J Am Acad Dermatol; 2012 May; 66(5):e167-78. PubMed ID: 20800318
[TBL] [Abstract][Full Text] [Related]
27. Functional analysis of novel sonic hedgehog gene mutations identified in basal cell carcinomas from xeroderma pigmentosum patients.
Couvé-Privat S; Le Bret M; Traiffort E; Queille S; Coulombe J; Bouadjar B; Avril MF; Ruat M; Sarasin A; Daya-Grosjean L
Cancer Res; 2004 May; 64(10):3559-65. PubMed ID: 15150112
[TBL] [Abstract][Full Text] [Related]
28. [Basal cell carcinoma. Molecular genetics and unusual clinical features].
Reifenberger J
Hautarzt; 2007 May; 58(5):406-11. PubMed ID: 17440702
[TBL] [Abstract][Full Text] [Related]
29. Hedgehog Pathway Alterations Downstream of Patched-1 Are Common in Infundibulocystic Basal Cell Carcinoma.
Russell-Goldman E; MacConaill L; Hanna J
Am J Dermatopathol; 2021 Apr; 43(4):266-272. PubMed ID: 32796174
[TBL] [Abstract][Full Text] [Related]
30. SHARPIN regulates cell proliferation of cutaneous basal cell carcinoma via inactivation of the transcriptional factors GLI2 and c‑JUN.
Yang Y; Liang YH; Zheng Y; Tang LJ; Zhou ST; Zhu JN
Mol Med Rep; 2020 Apr; 21(4):1799-1808. PubMed ID: 32319607
[TBL] [Abstract][Full Text] [Related]
31. Profile of Basal Cell Carcinoma Mutations and Copy Number Alterations - Focus on Gene-Associated Noncoding Variants.
Nawrocka PM; Galka-Marciniak P; Urbanek-Trzeciak MO; M-Thirusenthilarasan I; Szostak N; Philips A; Susok L; Sand M; Kozlowski P
Front Oncol; 2021; 11():752579. PubMed ID: 34900699
[TBL] [Abstract][Full Text] [Related]
32. Basal Cell Carcinoma With Matrical Differentiation: Clinicopathologic, Immunohistochemical, and Molecular Biological Study of 22 Cases.
Kyrpychova L; Carr RA; Martinek P; Vanecek T; Perret R; Chottová-Dvořáková M; Zamecnik M; Hadravsky L; Michal M; Kazakov DV
Am J Surg Pathol; 2017 Jun; 41(6):738-749. PubMed ID: 28368926
[TBL] [Abstract][Full Text] [Related]
33. The Role of Dermal Fibroblasts in Nevoid Basal Cell Carcinoma Syndrome Patients: An Overview.
Bellei B; Caputo S; Carbone A; Silipo V; Papaccio F; Picardo M; Eibenschutz L
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31979112
[TBL] [Abstract][Full Text] [Related]
34. p16 gene expression in basal cell carcinoma.
Eshkoor SA; Ismail P; Rahman SA; Oshkour SA
Arch Med Res; 2008 Oct; 39(7):668-73. PubMed ID: 18760195
[TBL] [Abstract][Full Text] [Related]
35. Loss-of-Function Variants in the Tumor-Suppressor Gene
Olafsdottir T; Stacey SN; Sveinbjornsson G; Thorleifsson G; Norland K; Sigurgeirsson B; Thorisdottir K; Kristjansson AK; Tryggvadottir L; Sarin KY; Benediktsson R; Jonasson JG; Sigurdsson A; Jonasdottir A; Kristmundsdottir S; Jonsson H; Gylfason A; Oddsson A; Fridriksdottir R; Gudjonsson SA; Zink F; Lund SH; Rognvaldsson S; Melsted P; Steinthorsdottir V; Gudmundsson J; Mikaelsdottir E; Olason PI; Stefansdottir L; Eggertsson HP; Halldorsson BV; Thorsteinsdottir U; Agustsson TT; Olafsson K; Olafsson JH; Sulem P; Rafnar T; Gudbjartsson DF; Stefansson K
Cancer Res; 2021 Apr; 81(8):1954-1964. PubMed ID: 33602785
[TBL] [Abstract][Full Text] [Related]
36. Expression of mismatch repair enzymes, hMLH1 and hMSH2 is not associated with microsatellite instability and P53 protein accumulation in basal cell carcinoma.
Saetta AA; Aroni K; Stamatelli A; Lazaris AC; Patsouris E
Arch Dermatol Res; 2005 Sep; 297(3):99-107. PubMed ID: 16012876
[TBL] [Abstract][Full Text] [Related]
37. Notch signaling is significantly suppressed in basal cell carcinomas and activation induces basal cell carcinoma cell apoptosis.
Shi FT; Yu M; Zloty D; Bell RH; Wang E; Akhoundsadegh N; Leung G; Haegert A; Carr N; Shapiro J; McElwee KJ
Mol Med Rep; 2017 Apr; 15(4):1441-1454. PubMed ID: 28259916
[TBL] [Abstract][Full Text] [Related]
38. Basal cell carcinoma: pathophysiology.
Sehgal VN; Chatterjee K; Pandhi D; Khurana A
Skinmed; 2014; 12(3):176-81. PubMed ID: 25134314
[TBL] [Abstract][Full Text] [Related]
39. Diagnosis and Management of Hereditary Basal Cell Skin Cancer.
Shanley S; McCormack C
Recent Results Cancer Res; 2016; 205():191-212. PubMed ID: 27075355
[TBL] [Abstract][Full Text] [Related]
40. Genetics of basal cell carcinoma.
de Zwaan SE; Haass NK
Australas J Dermatol; 2010 May; 51(2):81-92; quiz 93-4. PubMed ID: 20546211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
